Literature DB >> 3900528

Anemia of end-stage renal disease (ESRD).

J W Eschbach, J W Adamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3900528     DOI： 10.1038/ki.1985.109

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  47 in total

1.  Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.

Authors:  Hossein Mirinejad; Adam E Gaweda; Michael E Brier; Jacek M Zurada; Tamer Inanc
Journal:  Comput Methods Programs Biomed       Date:  2017-06-23       Impact factor: 5.428

2.  Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5.

Authors:  Ana de Lurdes Agostinho Cabrita; Ana Pinho; Anabela Malho; Elsa Morgado; Marília Faísca; Hermínio Carrasqueira; Ana Paula Silva; Pedro Leão Neves
Journal:  Int Urol Nephrol       Date:  2010-07-17       Impact factor: 2.370

3.  Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children.

Authors:  S Túri; I Németh; I Vargha; B Matkovics; E Dobos
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

4.  Characterization of a mouse model of chronic uremia.

Authors:  R F Gagnon; B Gallimore
Journal:  Urol Res       Date:  1988

5.  Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations.

Authors:  Fritz Sörgel; Ursula Thyroff-Friesinger; Andrea Vetter; Bernhard Vens-Cappell; Martina Kinzig
Journal:  Pharmacology       Date:  2008-12-22       Impact factor: 2.547

6.  Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).

Authors:  Wolfgang C Winkelmayer; Aya A Mitani; Benjamin A Goldstein; M Alan Brookhart; Glenn M Chertow
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

7.  Change in haemoglobin concentration, haematocrit and vasoactive hormones in haemodialysis patients with erythropoietin-associated hypertension.

Authors:  I Sasagawa; T Nakada; T Hashimoto; Y Kubota; H Suzuki; T Sawamura
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

8.  L-arginine administration reverses anemia associated with renal disease.

Authors:  Takahisa Tarumoto; Shigehiko Imagawa; Makoto Kobayashi; Aki Hirayama; Keiya Ozawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment.

Authors:  M Boran; C Küçükaksu; M Balk; S Cetin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

10.  Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

Authors:  Luiz Carlos Cichota; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; José Edson Paz da Silva
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.